Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « Mesh.i » - entrée « Castleman Disease »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Caspase 3 < Castleman Disease < Cat-Scratch Disease  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 99.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000008 (2020) C B Wu [République populaire de Chine] ; H Y Zhang [République populaire de Chine] ; S H Shao [République populaire de Chine] ; L W Dou [République populaire de Chine] ; Q Y Zhou [République populaire de Chine] ; Y. Liu [République populaire de Chine] ; W B Gao [République populaire de Chine] ; J H Zhu [République populaire de Chine][A report of six TAFRO syndrome: clinical characteristics, diagnosis and treatment analysis].
000264 (2019) Sisi Cai ; Zhaodong Zhong ; Xiang Li [République populaire de Chine] ; Hong Xiang Wang [République populaire de Chine] ; Li Wang [République populaire de Chine] ; Min ZhangTreatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report.
000290 (2019) Kazutoshi Ebisawa [Japon] ; Yosuke Masamoto [Japon] ; Junji Tokushige [Japon] ; Hiroshi Nishi [Japon] ; Kenjiro Honda [Japon] ; Munetoshi Hinata [Japon] ; Kazuhiro Toyama [Japon] ; Masaomi Nangaku [Japon] ; Mineo Kurokawa [Japon]Tocilizumab for focal segmental glomerulosclerosis secondary to multicentric Castleman's disease.
000299 (2019) Liyang Gu [Oman] ; Shuang YeTocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
000331 (2019) Ang Wei [République populaire de Chine] ; Honghao Ma [République populaire de Chine] ; Zhigang Li [République populaire de Chine] ; Liping Zhang [République populaire de Chine] ; Rui Zhang [République populaire de Chine] ; Tianyou Wang [République populaire de Chine]Successful treatment of a child with idiopathic multicentric Castleman disease associated with hemophagocytic lymphohistiocytosis using tocilizumab.
000452 (2019) Sakiko Tabata [Japon] ; Tomoaki Higuchi [Japon] ; Seishiro Tatsukawa [Japon] ; Kazuyuki Narimatsu [Japon] ; Hiroaki Takeo [Japon] ; Susumu Matsukuma [Japon] ; Toshimitsu Ito [Japon]Idiopathic Multicentric Castleman Disease with Autoimmune Hemolytic Anemia and Production of Anti-drug Antibody against Tocilizumab.
000518 (2019) Sofia Kourkounti [Grèce] ; Vasilios Paparizos [Grèce] ; Theodoros Retsas [Grèce] ; Amerini Dimitrakopoulou [Grèce] ; Dimitrios Rigopoulos [Grèce]Cutaneous vasculitis in HIV-associated Castleman's disease: a rare manifestation.
000541 (2019) Kei Suzuki [Japon] ; Takeshi Matsumoto [Japon] ; Yoshiaki Iwashita [Japon] ; Ken Ishikura [Japon] ; Masaki Fujioka [Japon] ; Hideo Wada [Japon] ; Naoyuki Katayama [Japon] ; Hiroshi Imai [Japon]Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab.
000589 (2019) Tomohiro Koga [Japon] ; Remi Sumiyoshi [Japon] ; Atsushi Kawakami [Japon] ; Kazuyuki Yoshizaki [Japon]A benefit and the prospects of IL-6 inhibitors in idiopathic multicentric Castleman's disease.
000622 (2018) Frits Van Rhee [États-Unis] ; Amy Greenway [États-Unis] ; Katie Stone [États-Unis]Treatment of Idiopathic Castleman Disease.
000644 (2018) Yumi Yamada ; Toshinori Ueno ; Taisuke Irifuku ; Ayumu Nakashima ; Shigehiro Doi ; Tatsuo Ichinohe ; Takao MasakiTocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.
000665 (2018) Masatoshi Matsunami [Japon] ; Yoshifumi Ubara [Japon] ; Keiichi Sumida [Japon] ; Yoichi Oshima [Japon] ; Masahiko Oguro [Japon] ; Kazuya Kinoshita [Japon] ; Kiho Tanaka [Japon] ; Yuki Nakamura [Japon] ; Keiichi Kinowaki [Japon] ; Kenichi Ohashi [Japon] ; Takeshi Fujii [Japon] ; Takuro Igawa [Japon] ; Yasuharu Sato [Japon] ; Yasuo Ishii [Japon]The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome.
000670 (2018) Kazuyuki Yoshizaki [Japon] ; Shinichi Murayama [Japon] ; Hiroki Ito [Japon] ; Tomohiro Koga [Japon]The Role of Interleukin-6 in Castleman Disease.
000677 (2018) Kazuya Sakai ; Takeshi Maeda ; Akira Kuriyama ; Noriaki Shimada ; Kenji Notohara [Japon] ; Yasunori UedaTAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
000682 (2018) Taiichiro Shirai ; Akira Onishi ; Daisuke Waki ; Jun Saegusa ; Akio MorinobuSuccessful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
000721 (2018) Hiroki Mizuno [Japon] ; Akinari Sekine [Japon] ; Masahiko Oguro [Japon] ; Yoichi Oshima [Japon] ; Masahiro Kawada [Japon] ; Keiichi Sumida [Japon] ; Masayuki Yamanouchi [Japon] ; Noriko Hayami [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Junichi Hoshino [Japon] ; Naoki Sawa [Japon] ; Takashi Fujii [Japon] ; Kenmei Takaichi [Japon] ; Kenichi Ohashi [Japon] ; Yoshifumi Ubara [Japon]Renal histology in a patient with TAFRO syndrome: a case report.
000780 (2018) Muhammad Bilal Abid [Royaume-Uni] ; Rachel Peck [Royaume-Uni] ; Muhammad Abbas Abid [États-Unis] ; Wesam Al-Sakkaf [Royaume-Uni] ; Yuening Zhang [Royaume-Uni] ; Giles S. Dunnill [Royaume-Uni] ; Konrad Staines [Royaume-Uni] ; Iara-Maria Sequeiros [Royaume-Uni] ; Lisa Lowry [Royaume-Uni]Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
000783 (2018) Frits Van Rhee [États-Unis] ; Peter Voorhees [États-Unis] ; Angela Dispenzieri [États-Unis] ; Alexander Foss [Norvège] ; Gordan Srkalovic [États-Unis] ; Makoto Ide [Japon] ; Nikhil Munshi [États-Unis] ; Stephen Schey [Royaume-Uni] ; Matthew Streetly [Royaume-Uni] ; Sheila K. Pierson [États-Unis] ; Helen L. Partridge [États-Unis] ; Sudipto Mukherjee [États-Unis] ; Dustin Shilling [États-Unis] ; Katie Stone [États-Unis] ; Amy Greenway [États-Unis] ; Jason Ruth [États-Unis] ; Mary Jo Lechowicz ; Shanmuganathan Chandrakasan [États-Unis] ; Raj Jayanthan [États-Unis] ; Elaine S. Jaffe [États-Unis] ; Heather Leitch [Canada] ; Naveen Pemmaraju [États-Unis] ; Amy Chadburn [États-Unis] ; Megan S. Lim ; Kojo S. Elenitoba-Johnson ; Vera Krymskaya [États-Unis] ; Aaron Goodman [États-Unis] ; Christian Hoffmann [Allemagne] ; Pier Luigi Zinzani [Italie] ; Simone Ferrero [Italie] ; Louis Terriou [France] ; Yasuharu Sato [Japon] ; David Simpson [Nouvelle-Zélande] ; Raymond Wong [Hong Kong] ; Jean-Francois Rossi [France] ; Sunita Nasta [États-Unis] ; Kazuyuki Yoshizaki [Japon] ; Razelle Kurzrock [États-Unis] ; Thomas S. Uldrick [États-Unis] ; Corey Casper [États-Unis] ; Eric Oksenhendler [France] ; David C. Fajgenbaum [États-Unis]International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
000863 (2018) Hiroaki Nishioka [Japon] ; Hiroshi Takegawa [Japon] ; Hiroki Kamei [Japon]Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease.
000926 (2018) Erika Van Nieuwenhove ; Stephanie Humblet-Baron ; Lien Van Eyck ; Lien De Somer ; James Dooley ; Thomas Tousseyn [Belgique] ; Michael Hershfield [États-Unis] ; Adrian Liston [Belgique] ; Carine WoutersADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease.
000990 (2017) Tatsuya Aoki [Japon] ; Mikio Wada [Japon] ; Atsushi Kawashima [Japon] ; Kouichi Hirakawa [Japon] ; Akihiro Nagata [Japon] ; Keizo Kagawa [Japon]Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Castleman Disease" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Castleman Disease" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Castleman Disease
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021